Clinical Trial Update: Efficacy and Safety of Quetiapine Compared With Valproate in the Treatment of Patients With Bipolar Disorder and Rapid Cycling [Phase 3]

View source ↗

Summary

The document reports a Phase 3 trial comparing quetiapine with valproate for bipolar disorder with rapid cycling that has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder

Drugs mentioned

• Quetiapine (quetiapine)
• Valproate (valproate)

Snippet

Sponsor: AstraZeneca | Conditions: Bipolar Disorder | Phase 3 | Status: COMPLETED